期刊文献+

重组复合α干扰素及其聚乙二醇化修饰产物理化性质研究 被引量:2

Study on Characterization of PEGylated and Native Consensus Interferon α
原文传递
导出
摘要 比较重组复合α干扰素(IFNcon)与经PEG修饰后产物的初步稳定性,测定其分子质量并进行分析。对IFNcon与PEG修饰IFNcon(PEG-IFNcon)进行60℃热稳定性,抗胰蛋白酶能力和人血清中稳定性的考察;比较IFNcon、monoPEG-IFNcon和oligoPEG-IFNcon的抗病毒生物活性;采用基质辅助激光解吸附飞行时间质谱(MALDI-TOF-MS)测定IFNcon和PEG-IFNcon的Mr;并利用SE-HPLC和SDS-PAGE对修饰产物进行分析。PEG-IFNcon的稳定性高于IFNcon;IFNcon、monoPEG-IFNcon和oligoPEG-IFNcon的抗病毒生物活性分别为6.72×108,8.1×107,4.0×106IU/mg;MALDI-TOF-MS测定IFNcon及PEG-IFNcon的Mr分别19613及62665;SDS-PAGE测得PEG-IFNcon表观Mr约100k;SE-HPLC测定IFNcon及PEG-IFNcon保留时间为28.855min和21.260min。经修饰,IFNcon稳定性显著提高,为该药物的临床研究提供理论基础。 Comparisons between native and PEGylated consensus interferon α on satiabbility were maae as well as the measurement and analysis of molecular weight were conducted. The thermal stability, the enzymolysis stability and the stability in human serum in vitro of PEG-IFNcon and native IFNcon were evaluated. It also tested the anti-viral activity of IFNeon, monoPEG-IFNcon and oligoPEG-IFNcon. Relative Mr of PEG-IFNcon and native IFNcon was detected by MALDI TOF-MS and then was analysised by SE HPLC and SDS-PAGE. The thermal stability, stability in serum and trypsin solution of PEG-IFNcon were significantly more stable than those of the IFNcon. The anti-viral activity of IFNcon, monoPEG-IFNcon and oligoPEG-IFNcon were 6.72× 10^8 8. 1 × 10^7 , 4. 0× 10^6 IU/mg respectively. Relative Mr of PEC-IFNcon was 62665 and native IFNcon was 19613 detected by MALDI-TOF- MS. The apparent Mr measured by SD-PAGE was about 100 k. Retention time of PEG-IFNcon detected by SE HPLC was 21. 260 rain and IFNcon was 28. 855 rain. Compared with IFNcon, PEG-IFNcon exhibits on improved stability and this may be helpful clinically for the research of medicine.
出处 《药物生物技术》 CAS CSCD 2009年第1期28-32,共5页 Pharmaceutical Biotechnology
基金 国家高技术研究发展计划(863计划)项目(2007AA02Z101) 国家自然科学基金(30672559) 教育部"新世纪优秀人才支持计划"项目(NCET-04-0506) 国家基础科学人才培养基金(J0630858)
关键词 重组复合α干扰素 PEG修饰 抗病毒生物活性 稳定性 分子质量 Recombinant consensus interferon α, PEGylation, Anti-viral activity, Stability, Molecular weight
  • 相关文献

参考文献12

  • 1Blatt L M, Davis JM, Klein SB, et al. The biologic activity and molecular characterization of a novel synthetic interferonalpha species, consensus interferon[J]. J Interferon Cytokine Res, 1996, 16(7):489.
  • 2Abuchowski A, McCoy JR, Palczuk NC, et al. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver eatatase[J]. J Biol Chem, 1977, 252:3582.
  • 3Abuchowski A, van Es T, Palczuk NC, et al. Ateration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol [J]. J Biol Chem, 1977, 252:3578.
  • 4Felix AM, Lu YA, Campbell RM. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs[J]. Int J Pept Protein Res, 1995, 46:253.
  • 5Mager DE, Neuteboom B, Jusko WJ. Pharmacokinetics and pharmaeodynamies of PEGylated IFN-beta la following subcutaneous administration in monkeys[J], pharm Res, 2005, 22:58.
  • 6Na DH, Lee KC, DeLuca PP. PEGylation of octretide:Ⅱ. Effect of N-terminal mono PEGylation on biological activity and pharmacokinelics[J]. Pizarro Res. 2005, 22:743.
  • 7Walsh S. Shah A. Mond J. Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conJugated to poly ethylene glyco[J]. AntimicrobAgents Chemother. 2003. 47: 554.
  • 8何明磊,熊玉春,魏东芝.新方法活化聚乙二醇修饰细胞因子类药物[J].药物生物技术,2005,12(3):158-161. 被引量:5
  • 9张雪梅,郭桥,吴福泉,陈云声,齐影,朱丽娜,周丽红,盛军,刘晶.聚乙二醇化重组人干扰素α2b的质量检测[J].中国生物制品学杂志,2005,18(1):48-50. 被引量:5
  • 10Farruggia B. NerliB. Nuci HD. et al. Thermal features of the bovine serum alhumin unfolding by polyethylene glycols [J]. lnt J Biol Macramol . 1999. 26:23.

二级参考文献11

  • 1周文孝,袁庆辉.聚乙二醇在生化药物化学修饰中的应用[J].中国药学杂志,1997,32(3):132-134. 被引量:10
  • 2.中国生物制品规程[M].,2000..
  • 3Jenog ST, Byun SM. Decreased agglutinability of methoxy-polyethylene glycol attached red blood cells: significance as a blood substitute. Artif Cells Blood Substit Immobil Biotechnol, 1996,24:503-511.
  • 4Mcgoff P, Baziotis AC, Maskiewicz R. Analysis of polyethylene glycol modified superoxide dismutase by chromatographic, light scattering,chemical and enzymatic mithods. Chem Pharm Bull Vol,1988,36(8):3079-3089.
  • 5Delgado C, Francis G E, Fisher D. The uses and properties of PEC-linked Proteins[J]. Crit Rev Ther Drug Carrier Syst,1992, 9(3-4):249.
  • 6Veronese F M, Harris J M. Introduction and overview of peptide and protein pegylation [J]. Advanced Drug Delivery Reviews,2002, 54: 453.
  • 7Timothy P K. The Synthesis of substituted methoxy-polyethylene glycol derivatives suitable for selective protein modification [J]. Synthetic communications, 1992,22(16)2417.
  • 8Snyder S I,, Sobocinski P Z. An improved 2, 4, 6-trinitrobenzenesulfonic acid method for the determination of amines[J]. Anal Chem,1975, 64(1):284.
  • 9卫生部生物制品标准化委员会.生物制品检定规程[R].北京:中国人口出版社,1995.268.
  • 10Gills S, Ferm M M, Ward D U. T-cell growth factor., parameters of production and a quantitative microassay for activity[J]. J Immunol, 1978, 120:2027.

共引文献7

同被引文献26

  • 1何明磊,熊玉春,魏东芝.新方法活化聚乙二醇修饰细胞因子类药物[J].药物生物技术,2005,12(3):158-161. 被引量:5
  • 2Veronese F M, and Pasut G. PEGylation, successful approach to drug delivery [ J ]. Drug Discov Today, 2005, 10 ( 21 ) : 1451-1458.
  • 3Qiu H, Boudanova E, Park A, et al. Site-specific PEGylation of human thyroid stimulating hormone to prolong duration of action [J]. Bioconjug Chem,2013,24(3) :408-418.
  • 4Huang Z, Ye C, Liu Z, et al. Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepha- rose column[J]. Bioconjug Chem,2012,23(4) :740-750.
  • 5Yoshioka Y, Tsutsumi Y, Ikemizu S, et al. Optimal site-specific PEGylation of mutant TNF-ct improves its antitumor potency[ J]. Biochem Bioph Res Co,2004,315(4) :808-814.
  • 6Youn Y S, Na D H, Lee K C. High-yield production of biologically active mono-PEGylated salmon calcitonin by site-specific PEGyla- tion [ J ]. J Control Rel,2007,117 (3) :371-379.
  • 7Youn Y S, Lee K C. Site-Specific PEGylation for High-Yield Preparation of Lys21-Amine PEGylated Growth Hormone-Relea- sing Factor ( GRF ) ( 1-29 ) iasing a GRF ( 1-29 ) Derivative FMOC-Protected at Tyrl and Lysl2 [ J]. Bioconjug Chem,2007, 18(2) :500-506.
  • 8Youn Y S, Chae S Y, Lee S,et al. Evaluation of therapeutic poten- tials of site-specific PEGylated glueagon-like peptide-lisomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose- stabilizing capability, and proteolytie stability [ J ]. Biochem Phar- macol,2007,73( 1 ) :84-93.
  • 9Brocehini S, Godwin A, Balan S, et al. Disulfide bridge based PEGylation of proteins [ J ]. Adv Drug Deliv Rev, 2008,60 ( 1 ) : 3-12.
  • 10Huang Z, Ni C, Chu Y, et al. Chemical modification of recombi- nant human keratinocyte growth factor 2 with polyethylene glycol improves biostability and reduces animal immunogenicity [ J ]. J Biotech ,2009,142 ( 3 ) :242-249.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部